Malaria in the Democratic Republic of Congo: how support programs consolidate elimination gains and protect at-risk populations from recrudescence
Aymar Akilimali(Roslin Institute), Amos Kipkorir Langat(African Centre for Technology Studies), Maria Qadri(Jinnah Sindh Medical University), Bonk Muhoza(Université Officielle de Bukavu), Godfred Yawson Scott(Kwame Nkrumah University of Science and Technology), Innocent Mufungizi(Green Circle), Calvin R. Wei(Unknown), Zubayer Shams(Brunel University of London), Charles Bisimwa(Université Officielle de Bukavu), Hafiza Tooba Siddiqui(Jinnah Sindh Medical University), Amidu Alhassan(University of Cape Coast), Zarnab Tufail(GIFT University), Daniel Bulondo(National Medical Association), Mc Juan Muco Mugisha, Ankini Mukherjee(Government Medical College), Muhammad Hanzalah Atif(Dow University of Health Sciences), Wanesa Wilczyńska(National Academy of Medicine), Sana Rasheed(Jinnah Sindh Medical University), Christian TAGUE, Ruchi Shah(M. P. Shah Medical College)
Cited by 2
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29